Walk in ridiculously prepared  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

A.I. & Robotics is Reshaping the Smart Home and Big Tech Wants In

A.I. & Robotics is Reshaping the Smart Home and Big Tech Wants In

Apple is rolling out Face-ID door locks and robotic smart displays. Elon Musk is quietly building the Tesla Smart Home. A.I. and robotics are driving the next wave of smart home innovation - and the window is open to invest in the companies that can define it.

One category is far bigger than most people realize: window shades. There are billions across homes, offices, and hotels - and almost all of them are still manual.

The last wave created major outcomes. Google bought Nest for $3.2 Billion. Amazon bought Ring for $1.2 Billion. Investors are now hunting for the next category leader - the one that can deliver real exit potential.

RYSE is leading this market with 10 patents, $15 million in revenue, and 200% annual growth. Their a prime acquisition target in a massive, untouched market. And RYSE is pre-IPO with a reserved Nasdaq ticker, giving investors exposure to multiple potential exit paths.

At $2.35 per share, this is your moment to get in before the next wave hits.

Get access to this pre-IPO investment opportunity.

*Ad

AlfaGap Insider

A no-nonsense research report for the retail investor. We identify the information gaps Wall Street ignores.

Download the top twelve stocks set to soar in 2026, despite the threat of tariffs and other economic uncertainty. These twelve stocks are resilient and likely to thrive in any economic environment.

Get your complimentary copy today before it goes back behind the paywall.

 

As we age, our muscles naturally lose mass, strength, and functionality, which can lead to fatigue and weakness beginning as early as our 30s. Recent studies indicate that our mitochondria-the cellular powerhouses that generate 90% of our energy-play a crucial role in this decline, contributing to reduced muscle function as we age. A new way to support and improve muscle health as we age, Mitopure® by Timeline is clinically shown to meaningfully boost our mitochondrial health to improve muscle strength, without any change in exercise required. Ready to feel stronger, for longer with Mitopure? Our readers can take 30% off their first month with code 30NEWSLETTER for a limited time. While supplies last.

Learn more

**500mg Mitopure® have been shown to (1) induce gene expression related to mitochondria function and metabolism and (2) increase the strength of the hamstring leg muscle in measures of knee extension and flexion after 4 months in overweight 40-65 year olds.

Crush Burnout with This Pro's AI Workflow

View Article

Your 3-month plan sorted

View Article

Cut Meeting Prep to 5 Minutes

View Article

5 tiny prompts beat 5 big apps

View Article

Stop Blaming the AI for Bad Images: Use This Structure Instead

View Article

Claudebot: The Open-Source AI That Beats Siri

View Article
 

Set sail,
Captain Yar

*Disclosure: Our free newsletter and website carry paid placements (marked "Sponsored", "Partnered" or "Ad") and sometimes use affiliate links. If you click or buy, we may earn a commission. We are not affiliated with these advertisers. That's just how we keep this newsletter free.

Update your email preferences or unsubscribe here

228 Park Ave S, #29976, New York, New York 10003, United States

Terms of Service